Clinical Trials Browser

Phase 1/2 × Lymphoma, Large B-Cell, Diffuse × copanlisib × Clear all

NCT04572763 2026-01-07

Copanlisib Plus Venetoclax in R/R DLBCL

Phase 1/2 Active not recruiting

Lymphoma, Large B-Cell, Diffuse